Prostate cancer (PC) etiology is up to 57% heritable, with the remainder attributed to environmental exposures. There are limited studies regarding national level environmental exposures and PC aggressiveness, which was the focus of this study METHODS: SEER was queried to identify PC cases between 2010 and 2014.
The prognostic significance of PSA bounce following definitive radiation therapy remains controversial. To develop a sense of current opinion in this area, we performed a systematic search of the literature based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Prostate cancer (PC) is the second most lethal cancer for men. For metastatic PC, standard first-line treatment is androgen deprivation therapy (ADT). While effective, ADT has many metabolic side effects.
Retrospective analyses of randomized trials suggest that Black men with metastatic castration-resistant prostate cancer (mCRPC) have longer survival than White men. The authors conducted a prospective study of abiraterone acetate plus prednisone to explore outcomes by race.
To evaluate trimodal conservative treatment as an alternative to radical surgery for urothelial muscle-invasive bladder cancer (MIBC). This retrospective study reported the carcinologic and functional results of patients (pts) presenting a cT2/T3 N0M0 operable MIBC and fit for surgery, treated by a conservative strategy.
Muscle invasive urothelial bladder carcinoma (MIBC) present RB1 and TP53 somatic alterations in a variable percentage of tumors throughout all molecular subtypes. MIBCs with neuroendocrine features have a high response rate to immunity checkpoint inhibitors (ICIs).
The benefit from the treatment of hormone-sensitive oligometastatic prostate cancer still remains unknown. There are multiple publications looking into such therapy that has grown significantly in the past 6 years, but unfortunately, we are facing a variety of definitions not only of what is considered “oligometastatic prostate cancer”, but also there is a variety of […]
Infertility impacts 15% of couples attempting to conceive, and a malefactor is involved in up to 50% of the time. Male infertility incidence varies across geographical locations and can range anywhere from 20 – 70%.1 Although there are many identifiable causes for male infertility, such as infection, hormonal abnormalities, varicocele, and malignancy to name a […]
New module creates a warped MRI scan that matches real-time ultrasound results to precisely locate clinically relevant regions and reduce procedural risks to patients. San Francisco, CA (UroToday.com) — RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, announced a new prostate MRI-to-ultrasound registration tool. The tool’s fully […]
San Francisco, CA (UroToday.com) — As Bladder Cancer Awareness Month kicks off, the National Institute of Health and Care Excellence (NICE) has announced that it is not recommending avelumab (Bavencio) for use as a maintenance treatment for people with locally advanced or metastatic urothelial (bladder) cancer after chemotherapy. This is deeply disappointing, and we urge NICE […]
